OpenURL Connection Search

Select item for more details and to access through your institution.

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.
Published in:
Psychopharmacology, 2004, v. 175, n. 3, p. 310, doi. 10.1007/s00213-004-1827-5
By:
- Campbell, Una C.;
- Lalwani, Kush;
- Hernandez, Lisa;
- Kinney, Gene G.;
- Conn, P. Jeffrey;
- Bristow, Linda J.
Publication type:
Article
Comprehensive bioimaging with fluorinated nanoparticles using breathable liquids.
Published in:
Nature Communications, 2015, v. 6, n. 1, p. 5998, doi. 10.1038/ncomms6998
By:
- Kurczy, Michael E.;
- Zhu, Zheng-Jiang;
- Ivanisevic, Julijana;
- Schuyler, Adam M.;
- Lalwani, Kush;
- Santidrian, Antonio F.;
- David, John M.;
- Giddabasappa, Anand;
- Roberts, Amanda J.;
- Olivos, Hernando J.;
- O'Brien, Peter J.;
- Franco, Lauren;
- Fields, Matthew W.;
- Paris, Liliana P.;
- Friedlander, Martin;
- Johnson, Caroline H.;
- Epstein, Adrian A.;
- Gendelman, Howard E.;
- Wood, Malcolm R.;
- Felding, Brunhilde H.
Publication type:
Article
Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.
Published in:
2012
By:
- Simmons BH;
- Lee JH;
- Lalwani K;
- Giddabasappa A;
- Snider BA;
- Wong A;
- Lappin PB;
- Eswaraka J;
- Kan JL;
- Christensen JG;
- Shojaei F;
- Simmons, Brett H;
- Lee, Joseph H;
- Lalwani, Kush;
- Giddabasappa, Anand;
- Snider, Brittany A;
- Wong, Anthony;
- Lappin, Patrick B;
- Eswaraka, Jeetendra;
- Kan, Julie L
Publication type:
journal article
Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras mice.
Published in:
Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 213, doi. 10.1007/s00280-012-1899-6
By:
- Simmons, Brett;
- Lee, Joseph;
- Lalwani, Kush;
- Giddabasappa, Anand;
- Snider, Brittany;
- Wong, Anthony;
- Lappin, Patrick;
- Eswaraka, Jeetendra;
- Kan, Julie;
- Christensen, James;
- Shojaei, Farbod
Publication type:
Article
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.
Published in:
BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-742
By:
- Eswaraka, Jeetendra;
- Giddabasappa, Anand;
- Guangzhou Han;
- Lalwani, Kush;
- Eisele, Koleen;
- Zheng Feng;
- Affolter, Timothy;
- Christensen, James;
- Gang Li
Publication type:
Article
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.
Published in:
2014
By:
- Eswaraka, Jeetendra;
- Giddabasappa, Anand;
- Han, Guangzhou;
- Lalwani, Kush;
- Eisele, Koleen;
- Feng, Zheng;
- Affolter, Timothy;
- Christensen, James;
- Li, Gang
Publication type:
journal article

Found: 6

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.

Comprehensive bioimaging with fluorinated nanoparticles using breathable liquids.

Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice.

Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras mice.

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.